|
Canada-0-HardwareRetail ไดเรกทอรีที่ บริษัท
|
ข่าว บริษัท :
- Financial Toxicity, Part I: A New Name for a Growing Problem
In this, the first part of a two-part series, we will describe the patient-level impact of the cost of cancer care, what we call “financial toxicity ” In Part II we will consider potential interventions to alleviate financial toxicity
- Financial toxicity, Part I: a new name for a growing problem.
Zafar, S Y , Abernethy, A P (2013) Financial toxicity, Part I: a new name for a growing problem Oncology Williston Park N Y, 27 (2), 80–149
- HHS Public Access Amy P. Abernethy, MD Oncology (Williston Park)
HHS Public Access Author manuscript Oncology (Williston Park) Author manuscript; available in PMC 2015 August 04 Published in final edited form as: Oncology (Williston Park) 2013 February ; 27(2): 80–149
- Financial toxicity, Part I: a new name for a growing problem.
Zafar, S Y , Abernethy, A P (2013) Financial toxicity, Part I: a new name for a growing problem Oncology (Williston Park), 27 (2), 80–149
- Financial toxicity, Part I: a new name for a growing problem.
作者： S Yousuf,Zafar [1]; Amy P,Abernethy 作者单位：Center for Learning Health Care, Duke Clinical Research Institute, Duke Cancer Institute, Durham, North Carolina, USA [1]
- Financial Toxicity, Part I: A New Name for a Growing Problem
Financial toxicity (FT) is characterized as economic hardship or damage as a result of cancer treatment, which is the consequence of objective financial distress and subjective psychological
- Financial toxicity, Part I: a new name for a growing problem.
Financial toxicity, Part I: a new name for a growing problem 来自 NCBI 喜欢 0 阅读量： 374
- Financial Toxicity, Part I: A New Name for a Growing Problem
In this, the first part of a two-part series, we will describe the patient-level impact of the cost of cancer care, what we call “financial toxicity ” In Part II we will consider potential interventions to alleviate financial toxicity
- Zafar, S. Y. and Abernethy, A. P. (2013) Financial Toxicity, Part I A New . . .
ABSTRACT: This research is to investigate the level of economic toxicity and its associated influencing factors among lung cancer patients undergoing chemotherapy, and to provide guidance for the development of an economic toxicity screening tool
- Financial toxicity, Part I: a new name for a growing problem.
While claims datasets consistently report an association between financial burden quality care, the impact on traditional disease-related outcomes—survival, for example—have not been assessed
|
|